Full data view for gene LDLR

Information The variants shown are described using the NM_000527.4 transcript reference sequence.

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Enzyme activity     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/+? 1 c.-138del r.(=) p.(=) SP1 binding site 24% LDLR activity in Htz lymphocytes. Reduced level of expression conservation: 12/13 conservation {PMID25248394:Khamis et al European Journal of Human Genetics (2015) 23, 790–795} Parent #1 ACGS likely pathogenic g.11200087del g.11089411del c.-138delT, FH Pyrgos - LDLR_000959 predicted reduced levels of transcription; Hobbs' numbering: -45delT. PubMed: Dedoussis 2003 - - Germline - - - - - DNA SEQ - - FH - PubMed: Dedoussis 2003 - - - Greece GR - - - - 1 Sarah Leigh
+/. - c.-138del r.(?) p.(=) - - - Unknown - pathogenic g.11200087del g.11089411del LDLR(NM_000527.5):c.-138delT - LDLR_000959 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.